XML 59 R43.htm IDEA: XBRL DOCUMENT
v3.26.1

Note 13 - Shareholders' Equity (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2025
Notes Tables |
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] |
|  | For the Year Ended December 31, |
(In thousands, except per share data) |  | 2025 |  |  | 2024 |  |  | 2023 |
Net Income: |  |  |  |  |  |  |  |  |  |  |  |
Net income |  | $ | 29,617 |  |  | $ | 28,619 |  |  | $ | 29,776 |
Earnings Per Share: |  |  |  |  |  |  |  |  |  |  |  |
Basic earnings per share |  | $ | 4.60 |  |  | $ | 4.85 |  |  | $ | 5.08 |
Diluted earnings per share |  | $ | 4.54 |  |  | $ | 4.80 |  |  | $ | 5.02 |
Weighted Average Number of Shares Outstanding: |  |  |  |  |  |  |  |  |  |  |  |
Basic shares |  |  | 6,440 |  |  |  | 5,895 |  |  |  | 5,863 |
Effect of dilutive of stock options and restricted stock |  |  | 77 |  |  |  | 73 |  |  |  | 71 |
Diluted shares |  |  | 6,517 |  |  |  | 5,968 |  |  |  | 5,934 |
Share-Based Payment Arrangement, Option, Activity [Table Text Block] |
|  |  |  |  |  |  |  |  |  | Weighted |  |  |  |  |
|  |  |  |  |  |  |  |  |  | Average |  |  |  |  |
|  |  |  |  |  | Weighted |  |  | Remaining |  |  |  |  |
|  |  |  |  |  | Average |  |  | Contractual |  |  |  |  |
|  |  |  |  |  | Exercise |  |  | Term in |  |  | Intrinsic |
|  | Shares |  |  | Price |  |  | Years |  |  | Value |
Options outstanding at January 1, 2023 |  |  | 189,917 |  |  | $ | 21.14 |  |  |  |  |  |  |  |  |
Options exercised |  |  | (24,400 | ) |  | $ | 18.59 |  |  |  |  |  |  |  |  |
Options outstanding at December 31, 2023 |  |  | 165,517 |  |  | $ | 21.52 |  |  |  |  |  |  |  |  |
Options cancelled |  |  | (1,600 | ) |  | $ | 24.40 |  |  |  |  |  |  |  |  |
Options exercised |  |  | (32,070 | ) |  | $ | 17.03 |  |  |  |  |  |  |  |  |
Options outstanding at December 31, 2024 |  |  | 131,847 |  |  | $ | 22.58 |  |  |  |  |  |  |  |  |
Options cancelled |  |  | (3,200 | ) |  | $ | 22.19 |  |  |  |  |  |  |  |  |
Options exercised |  |  | (45,505 | ) |  | $ | 22.64 |  |  |  |  |  |  |  |  |
Options outstanding at December 31, 2025 |  |  | 83,142 |  |  | $ | 22.56 |  |  |  | 1.2 |  |  | $ | 1,840,328 |
Options exercisable at December 31, 2025 |  |  | 83,142 |  |  | $ | 22.56 |  |  |  | 1.2 |  |  | $ | 1,840,328 |
|  | Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term in Years |  |  | Intrinsic Value |
Options outstanding at January 1, 2023 |  |  | 117,200 |  |  | $ | 31.00 |  |  |  |  |  |  |  |  |
Options cancelled |  |  | (10,400 | ) |  | $ | 31.00 |  |  |  |  |  |  |  |  |
Options exercised |  |  | (1,300 | ) |  | $ | 31.00 |  |  |  |  |  |  |  |  |
Options outstanding at December 31, 2023 |  |  | 105,500 |  |  | $ | 31.00 |  |  |  |  |  |  |  |  |
Options granted |  |  | 107,200 |  |  | $ | 34.07 |  |  |  |  |  |  |  |  |
Options cancelled |  |  | (1,200 | ) |  | $ | 34.07 |  |  |  |  |  |  |  |  |
Options exercised |  |  | (1,300 | ) |  | $ | 31.00 |  |  |  |  |  |  |  |  |
Options outstanding at December 31, 2024 |  |  | 210,200 |  |  | $ | 32.55 |  |  |  |  |  |  |  |  |
Options granted |  |  | 30,803 |  |  | $ | 31.09 |  |  |  |  |  |  |  |  |
Options cancelled |  |  | (21,980 | ) |  | $ | 32.41 |  |  |  |  |  |  |  |  |
Options exercised |  |  | (5,100 | ) |  | $ | 31.36 |  |  |  |  |  |  |  |  |
Options outstanding at December 31, 2025 |  |  | 213,923 |  |  | $ | 32.38 |  |  |  | 7.2 |  |  | $ | 2,633,200 |
Options exercisable at December 31, 2025 |  |  | 100,278 |  |  | $ | 31.60 |  |  |  | 6.7 |  |  | $ | 1,312,809 |
Expected to vest after December 31, 2025 |  |  | 95,936 |  |  | $ | 33.16 |  |  |  | 7.6 |  |  | $ | 1,106,111 |
Share-Based Payment Arrangement, Cost by Plan [Table Text Block] |
|  | 2025 |  |  | 2024 |
Fair value of options vested |  | $ | 361,000 |  |  | $ | 199,000 |
Intrinsic value of options exercised |  | $ | 1,087,000 |  |  | $ | 700,000 |
Cash received from option exercises |  | $ | 1,105,000 |  |  | $ | 508,000 |
Tax benefit from option exercises |  | $ | 93,000 |  |  | $ | 83,000 |
Compensation cost |  | $ | 343,000 |  |  | $ | 393,000 |
Tax benefit associated with compensation cost |  | $ | 23,000 |  |  | $ | 51,000 |
Schedule of Compliance with Regulatory Capital Requirements under Banking Regulations [Table Text Block] |
|  |  |  |  |  |  |  |  |  | Minimum Amount of Capital Required |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | To be Well-Capitalized |
|  |  |  |  |  |  |  |  |  | For Capital |  |  | Under Prompt |
|  | Actual |  |  | Adequacy Purposes (1) |  |  | Corrective Provisions |
|  | Amount |  |  | Ratio |  |  | Amount |  |  | Ratio |  |  | Amount |  |  | Ratio |
December 31, 2025 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Equity Tier 1 Ratio |  | $ | 247,747 |  |  |  | 14.8 | % |  | $ | 75,265 |  |  |  | 4.5 | % |  | $ | 108,717 |  |  |  | 6.5 | %
Tier 1 Leverage Ratio |  |  | 247,747 |  |  |  | 11.1 | % |  |  | 89,237 |  |  |  | 4.0 | % |  |  | 111,547 |  |  |  | 5.0 | %
Tier 1 Risk-Based Capital Ratio |  |  | 247,747 |  |  |  | 14.8 | % |  |  | 100,354 |  |  |  | 6.0 | % |  |  | 133,805 |  |  |  | 8.0 | %
Total Risk-Based Capital Ratio |  |  | 268,285 |  |  |  | 16.0 | % |  |  | 133,805 |  |  |  | 8.0 | % |  |  | 167,257 |  |  |  | 10.0 | %
December 31, 2024 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Equity Tier 1 Ratio |  | $ | 199,308 |  |  |  | 17.3 | % |  | $ | 51,981 |  |  |  | 4.5 | % |  | $ | 75,084 |  |  |  | 6.5 | %
Tier 1 Leverage Ratio |  |  | 199,308 |  |  |  | 11.9 | % |  |  | 66,856 |  |  |  | 4.0 | % |  |  | 83,570 |  |  |  | 5.0 | %
Tier 1 Risk-Based Capital Ratio |  |  | 199,308 |  |  |  | 17.3 | % |  |  | 69,308 |  |  |  | 6.0 | % |  |  | 92,411 |  |  |  | 8.0 | %
Total Risk-Based Capital Ratio |  |  | 213,124 |  |  |  | 18.5 | % |  |  | 92,411 |  |  |  | 8.0 | % |  |  | 115,514 |  |  |  | 10.0 | %

X
- Definition Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the capital amounts and ratios as of the balance sheet date, indicating whether the entity or entities are in compliance with regulatory capital requirements, by entity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 942 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477270/942-505-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 942 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Publisher FASB -URI https://asc.fasb.org/1943274/2147477270/942-505-50-1B + Details
Name: | us-gaap_ScheduleOfComplianceWithRegulatoryCapitalRequirementsUnderBankingRegulationsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_TableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration